ABL1 is highly expressed in the lymphocytes of CLL, and the inhibitor of ABL-family protein tyrosine kinases imatinib mesylate (imatinib) has been shown to induce the apoptosis of neoplastic CLL B-lymphocytes in vitro[14]. The gene discussed is ABL1; the disease is B-cell chronic lymphocytic leukemia.